huashi baidu

consists of glycyrrhiza, apricot kernel, agastache rugosus, magnolia officinalis, atractylodes, amomum tsao-ko, pinellia ternate, poria cocos, rhubarb, astragalus, lepidium seed, red peony root, and ephedra

Networked: 20 relevant articles (5 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Qi, Fanghua: 2 articles (09/2021 - 01/2020)
2.	Fan, Qin: 1 article (01/2022)
3.	Greenhalgh, Trisha: 1 article (01/2022)
4.	Jin, Xiaojie: 1 article (01/2022)
5.	Li, Chaoxin: 1 article (01/2022)
6.	Li, Chenghao: 1 article (01/2022)
7.	Li, Jiawei: 1 article (01/2022)
8.	Li, Ling: 1 article (01/2022)
9.	Ling, Jia: 1 article (01/2022)
10.	Liu, Xiuzhu: 1 article (01/2022)

Related Diseases

1.	COVID-19 11/03/2023 - "Huashi Baidu(HSBD) Granules have played a great role in fighting against COVID-19. " 01/01/2023 - "We conducted a single-center, open-label, parallel-group randomized controlled trial to assess the efficacy and safety of a Chinese herb compound, Huashi Baidu granule (HSBDG) in pediatric patients with laboratory-confirmed mild COVID-19. " 01/01/2023 - "Huashi baidu granule in the treatment of pediatric patients with mild coronavirus disease 2019: A single-center, open-label, parallel-group randomized controlled clinical trial." 04/01/2021 - "The pharmacological mechanism of Huashi Baidu Formula for the treatment of COVID-19 by combined network pharmacology and molecular docking." 03/01/2021 - "Huashi Baidu Decoction (HSBD) is a novel complex prescription which has positive effects on severe COVID-19. "
2.	Pneumonia (Pneumonitis) 10/16/2020 - "In China, the combination of Huashi Baidu Formula (HBF) and antiviral drugs is used in the clinical treatment of severe patients with new coronary pneumonia, but there is still a lack of evidence-based medical evaluation. " 06/01/2021 - "Huashi Baidu prescription (HSBDF), recommended in the Guideline for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Pneumonia (On Trials, the Seventh Edition), was clinically used to treat severe corona virus disease 2019 (COVID-19) with cough, blood-stained sputum, inhibited defecation, red tongue etc. symptoms. "
3.	Acute Lung Injury 01/01/2022 - "The Huashi Baidu Formula (HSBDF), a key Chinese medical drug, has a remarkable clinical efficacy in treating acute lung injury (ALI), and it has been officially approved by the National Medical Products Administration of China for drug clinical trials. "
4.	Virus Diseases (Viral Diseases) 06/01/2021 - "Huashi Baidu prescription (HSBDF), recommended in the Guideline for the Diagnosis and Treatment of Novel Coronavirus (2019-nCoV) Pneumonia (On Trials, the Seventh Edition), was clinically used to treat severe corona virus disease 2019 (COVID-19) with cough, blood-stained sputum, inhibited defecation, red tongue etc. symptoms. "
5.	Human Influenza (Influenza) 11/03/2023 - "This study is intended to apply Huashi Baidu Granules to treat influenza with exterior-cold and interior-heat syndrome to identify the clinical efficacy and safety of this recipe. " 11/03/2023 - "Efficacy and Safety of Huashi Baidu Granules in the Treatment of Children Suffering from Influenza with Exterior-cold and Interior-heat Syndrome: A Multi-center, Randomized Controlled Trial Protocol."

Related Drugs and Biologics

1.	Xuebijing
2.	xuanfei baidu
3.	jinhua qinggan granules
4.	qingfei paidu decoction
5.	Antiviral Agents (Antivirals)
6.	Capsules (Microcapsules)
7.	Lopinavir
8.	Ritonavir (Norvir)
9.	Therapeutic Uses
10.	Glycyrrhizic Acid (Glycyrrhizin)

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)
2.	Therapeutics
3.	Injections